by nikki mann | Jun 10, 2024 | News
Work at the Milner Therapeutics Institute in collaboration with Professor Matthias Zilbauer has made a promising step toward identifying more precise and personalised treatments for patients with Crohn’s disease. The research published today in Gut reports how Milner...
by nikki mann | May 20, 2024 | News
We are delighted to announce that Chun Hao Wong has joined the Milner team as the MTI lead for the new MRC-AstraZeneca-University of Cambridge Functional Genomics Screening Laboratory (FGSL). The FGSL aims to combine know-how and experience to accelerate the...
by nikki mann | Apr 18, 2024 | News
This year the Milner Institute was delighted to take part in the University of Cambridge’s interdisciplinary Cambridge Festival. The Festival takes place each Spring and includes a mixture of online, on-demand and in-person events covering all aspects of the...
by nikki mann | Mar 26, 2024 | News
The functional genomics screening laboratory (FGSL), a joint venture between our Institute at the University of Cambridge, the Medical Research Council (MRC) and AstraZeneca, has opened a call for project proposals. The call, which opened on 26th March, is relevant to...
by nikki mann | Mar 4, 2024 | News
We are delighted that our Head of Computational Biology and AI, Dr Namshik Han, was featured on Cytiva’s ‘Discovery Matters’ podcast series last month. Cytiva – a Milner affiliated company – use their podcast series to bring together experts from across the life...
by nikki mann | Nov 30, 2023 | News
We are delighted to announce that our Frame Shift Bio-incubator has expanded this month, with the opening of a second hub in the city centre, based at the Gurdon Institute. The Frame Shift – City Centre hub will allow further growth for selected companies before they...